Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             172 results found
no title author magazine year volume issue page(s) type
1 A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus Goard, Carolyn A.
2007
3 p. 303-312
10 p.
article
2 Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells Shu, Minfeng
2011
3 p. 265-272
8 p.
article
3 A DNA methylation-based definition of biologically distinct breast cancer subtypes Stefansson, Olafur A.
2015
3 p. 555-568
14 p.
article
4 Adseverin: A novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis Miura, Noriyoshi
2012
3 p. 311-322
12 p.
article
5 ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer Arcaroli, John J.
2012
3 p. 370-381
12 p.
article
6 Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration Dutta, Sujoy
2014
3 p. 483-507
25 p.
article
7 An interview with Alexander Eggermont Fricker, Janet
2009
3 p. 188-191
4 p.
article
8 An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma Zhang, Yan
2013
3 p. 346-358
13 p.
article
9 Barriers to translation of research Gannon, Frank
2007
3 p. 244-245
2 p.
article
10 Biobanking for better healthcare Riegman, Peter H.J.
2008
3 p. 213-222
10 p.
article
11 Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients Siravegna, Giulia
2016
3 p. 475-480
6 p.
article
12 Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses Abbasi, M. Reza
2015
3 p. 545-554
10 p.
article
13 BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation Stordal, Britta
2013
3 p. 567-579
13 p.
article
14 Cell-free circulating tumour DNA as a liquid biopsy in breast cancer De Mattos-Arruda, Leticia
2016
3 p. 464-474
11 p.
article
15 Challenges in circulating tumor cell detection by the CellSearch system Andree, Kiki C.
2016
3 p. 395-407
13 p.
article
16 Circulating free xeno-microRNAs – The new kids on the block Fabris, Linda
2016
3 p. 503-508
6 p.
article
17 Circulating tumor cells in breast cancer Bidard, Francois-Clement
2016
3 p. 418-430
13 p.
article
18 Circulating tumor cell technologies Ferreira, Meghaan M.
2016
3 p. 374-394
21 p.
article
19 Clinical and biological significance of circulating tumor cells in cancer Masuda, Takaaki
2016
3 p. 408-417
10 p.
article
20 Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer Riva, Francesca
2016
3 p. 481-493
13 p.
article
21 Conference calendar 2008
3 p. 282-284
3 p.
article
22 Conference calendar 2007
3 p. 356-358
3 p.
article
23 Conference calendar 2009
3 p. 269-
1 p.
article
24 Contents of Molecular Oncology Volume 2 2008
3 p. 285-287
3 p.
article
25 Contents of Molecular Oncology Volume 3 2009
3 p. 270-272
3 p.
article
26 Corrigendum to “Tracing the tumor lineage” [Mol. Oncol. 4 (2010) 267–283] Navin, Nicholas E.
2011
3 p. 302-
1 p.
article
27 CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas Chen, Wangbing
2014
3 p. 704-716
13 p.
article
28 Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas Spector, Yael
2013
3 p. 732-738
7 p.
article
29 Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma Carlino, Matteo S.
2014
3 p. 544-554
11 p.
article
30 Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies Rockberg, Johan
2009
3 p. 238-247
10 p.
article
31 DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity van Jaarsveld, Marijn T.M.
2014
3 p. 458-468
11 p.
article
32 DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts Abdel-Fatah, Tarek M.A.
2014
3 p. 520-532
13 p.
article
33 Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells Nam, Sangkil
2013
3 p. 369-378
10 p.
article
34 Ectopic expression of plasma membrane targeted subunits of the Ndc80-complex as a tool to study kinetochore biochemistry Holmström, Tim H.
2009
3 p. 262-268
7 p.
article
35 Editorial Board 2015
3 p. ii-
1 p.
article
36 Editorial Board 2008
3 p. ii-
1 p.
article
37 Editorial Board 2007
3 p. ii-
1 p.
article
38 Editorial Board 2009
3 p. ii-
1 p.
article
39 Editorial Board 2010
3 p. ii-
1 p.
article
40 Editorial board 2014
3 p. ii-
1 p.
article
41 Editorial Board 2016
3 p. ii-
1 p.
article
42 Editorial Board 2013
3 p. ii-
1 p.
article
43 Editorial Board 2011
3 p. ii-
1 p.
article
44 Editorial Board 2012
3 p. ii-
1 p.
article
45 Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT Brahimi-Adouane, Sabrina
2013
3 p. 323-333
11 p.
article
46 EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells Chiu, Huan-Chih
2012
3 p. 299-310
12 p.
article
47 Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine Johnson, Charlotte E.
2015
3 p. 675-688
14 p.
article
48 Estradiol–estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells Kousidou, Olga Ch.
2008
3 p. 223-232
10 p.
article
49 Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells Li, Guangliang
2013
3 p. 611-624
14 p.
article
50 EVI1 splice variants modulate functional responses in ovarian cancer cells Dutta, Punashi
2013
3 p. 647-668
22 p.
article
51 Exon 2 deletion splice variant of γ-glutamyl carboxylase causes des-γ-carboxy prothrombin production in hepatocellular carcinoma cell lines Ueda, Naoki
2008
3 p. 241-249
9 p.
article
52 FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia Kazi, Julhash U.
2013
3 p. 402-418
17 p.
article
53 Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution Zhou, Wenjing
2009
3 p. 214-219
6 p.
article
54 Functional studies on circulating and disseminated tumor cells in carcinoma patients Alix-Panabières, Catherine
2016
3 p. 443-449
7 p.
article
55 Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors Huisman, Christian
2013
3 p. 669-679
11 p.
article
56 Gene expression profiling and DNA methylation analyses of CTCs Lianidou, Evi S.
2016
3 p. 431-442
12 p.
article
57 Genetic susceptibility to breast cancer Mavaddat, Nasim
2010
3 p. 174-191
18 p.
article
58 Genomic instability in breast cancer: Pathogenesis and clinical implications Kwei, Kevin A.
2010
3 p. 255-266
12 p.
article
59 Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2 Li, Likun
2013
3 p. 484-496
13 p.
article
60 Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue Aktas, Bilge
2014
3 p. 717-727
11 p.
article
61 Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer community Sullivan, Richard
2009
3 p. 192-203
12 p.
article
62 HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression Cartron, Pierre-François
2013
3 p. 452-463
12 p.
article
63 HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer Boulbes, Delphine R.
2015
3 p. 586-600
15 p.
article
64 Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: Implications for tumor angiogenesis Åkerblom, Björn
2012
3 p. 333-346
14 p.
article
65 High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer Rasmussen, Mads H.
2013
3 p. 637-646
10 p.
article
66 High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097 He, Wei
2011
3 p. 292-301
10 p.
article
67 Histological types of breast cancer: How special are they? Weigelt, Britta
2010
3 p. 192-208
17 p.
article
68 Honokiol inhibits epithelial–mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis Avtanski, Dimiter B.
2014
3 p. 565-580
16 p.
article
69 Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein Facciuto, Florencia
2014
3 p. 533-543
11 p.
article
70 Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7 Lindquist, David
2007
3 p. 350-355
6 p.
article
71 Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease Celis, Julio E.
2007
3 p. 321-349
29 p.
article
72 Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer Bayani, Jane
2008
3 p. 250-260
11 p.
article
73 Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling Nam, Sangkil
2012
3 p. 276-283
8 p.
article
74 Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins Myhre, Simen
2013
3 p. 704-718
15 p.
article
75 Infrastructure for translational research in Asia Harris Cheng, Margaret
2007
3 p. 255-257
3 p.
article
76 Inhibition of NEDD8-conjugation pathway by novel molecules: Potential approaches to anticancer therapy Tanaka, Tomoaki
2012
3 p. 267-275
9 p.
article
77 Inside the European Science Foundation Fricker, Janet
2008
3 p. 197-199
3 p.
article
78 Is metastasis predetermined? Weinberg, Robert A.
2007
3 p. 263-264
2 p.
article
79 KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells Mohan, Nishant
2013
3 p. 464-474
11 p.
article
80 Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells Giordano, Cinzia
2013
3 p. 379-391
13 p.
article
81 Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab Mamidi, Srinivas
2013
3 p. 580-594
15 p.
article
82 Liquid biopsy: Potential and challenges Pantel, Klaus
2016
3 p. 371-373
3 p.
article
83 Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients Huang, Sharon K.
2016
3 p. 450-463
14 p.
article
84 Looking back, to go forward Moreira, José M.A.
2014
3 p. 445-446
2 p.
article
85 Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy Moestue, Siver Andreas
2011
3 p. 224-241
18 p.
article
86 Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer Wei, Siwei
2013
3 p. 297-307
11 p.
article
87 Micro-RNAs and breast cancer Le Quesne, John
2010
3 p. 230-241
12 p.
article
88 MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein Yao, Yilong
2015
3 p. 640-656
17 p.
article
89 miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 Kronski, Emanuel
2014
3 p. 581-595
15 p.
article
90 miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization Valencia, Karmele
2014
3 p. 689-703
15 p.
article
91 miRNA expression profiling of mycosis fungoides van Kester, Marloes S.
2011
3 p. 273-280
8 p.
article
92 MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma Kirschner, Michaela B.
2015
3 p. 715-726
12 p.
article
93 Molecular basis for therapy resistance Lønning, Per E.
2010
3 p. 284-300
17 p.
article
94 Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort Celis, Julio E.
2009
3 p. 220-237
18 p.
article
95 Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts Topp, Monique D.
2014
3 p. 656-668
13 p.
article
96 Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition Young, Natalie R.
2013
3 p. 359-368
10 p.
article
97 Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer Smerage, Jeffrey B.
2013
3 p. 680-692
13 p.
article
98 Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients Tobin, Nicholas P.
2014
3 p. 741-752
12 p.
article
99 Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress Maya-Mendoza, Apolinar
2015
3 p. 601-616
16 p.
article
100 MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S Bénard, Jean
2008
3 p. 261-271
11 p.
article
101 Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells Olszewski, Ulrike
2009
3 p. 204-213
10 p.
article
102 New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family Emami, Nashmil
2007
3 p. 269-287
19 p.
article
103 New members of the Editorial Board 2011
3 p. 215-216
2 p.
article
104 News from ECCO Fricker, Janet
2007
3 p. 258-262
5 p.
article
105 NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53 Choi, Yongwook
2014
3 p. 642-655
14 p.
article
106 Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies Heitzer, Ellen
2016
3 p. 494-502
9 p.
article
107 N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy Martin, Sarah K.
2015
3 p. 628-639
12 p.
article
108 Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: Role of adipokines Malvi, Parmanand
2015
3 p. 689-703
15 p.
article
109 On the molecular biology of breast cancer Børresen-Dale, Anne-Lise
2010
3 p. 171-173
3 p.
article
110 Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity Porcelli, Letizia
2013
3 p. 308-322
15 p.
article
111 Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours Ferreira, José Alexandre
2013
3 p. 719-731
13 p.
article
112 Patient advocacy groups: Empowering patients in their fight against cancer Fricker, Janet
2007
3 p. 252-254
3 p.
article
113 Patient-derived xenografts recapitulate molecular features of human uveal melanomas Laurent, Cécile
2013
3 p. 625-636
12 p.
article
114 Patient organisations aim for greater collaboration Wilkinson, Emma
2008
3 p. 200-202
3 p.
article
115 Personal Profiles 2007
3 p. 237-243
7 p.
article
116 Personal Profiles 2009
3 p. 187-
1 p.
article
117 Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor Sato, Kazuhide
2014
3 p. 620-632
13 p.
article
118 Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model Hafeez, Bilal Bin
2013
3 p. 428-439
12 p.
article
119 Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 Green, Tim P.
2009
3 p. 248-261
14 p.
article
120 Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector Kobelt, Dennis
2014
3 p. 609-619
11 p.
article
121 Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature Hayes, Josie
2015
3 p. 704-714
11 p.
article
122 Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics Sharma, Sharad
2014
3 p. 469-482
14 p.
article
123 Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib Singh, Anjali
2013
3 p. 497-512
16 p.
article
124 Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years Pierga, J.-Y.
2007
3 p. 267-268
2 p.
article
125 Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients Draht, Muriel X.G.
2014
3 p. 679-688
10 p.
article
126 Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers Sung, Chang K.
2013
3 p. 419-427
9 p.
article
127 Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells Park, Ji Hyun
2015
3 p. 617-627
11 p.
article
128 Protein inhibitor of activated STAT3 expression in lung cancer Kluge, Amy
2011
3 p. 256-264
9 p.
article
129 Protein Shakes – the future is not here yet for proteomic–based companion diagnostics, but it's coming Dumiak, Michael
2011
3 p. 220-223
4 p.
article
130 p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation Segatto, Ilenia
2014
3 p. 766-780
15 p.
article
131 Quantifying initial cellular events of mouse radiation lymphomagenesis and its tumor prevention in vivo by positron emission tomography and magnetic resonance imaging Hasegawa, Sumitaka
2015
3 p. 740-748
9 p.
article
132 Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491 Luxton, Hayley J.
2014
3 p. 633-641
9 p.
article
133 Response to “Is metastasis predetermined?” Tarin, David
2007
3 p. 265-266
2 p.
article
134 Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12 Malvicini, Mariana
2011
3 p. 242-255
14 p.
article
135 Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer Roth, Carina
2011
3 p. 281-291
11 p.
article
136 Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis Matthess, Yves
2014
3 p. 596-608
13 p.
article
137 Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response Chen, Yu-Li
2012
3 p. 360-369
10 p.
article
138 Shaping science policy in Europe Celis, Julio E.
2014
3 p. 447-457
11 p.
article
139 Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients Qu, Falin
2015
3 p. 727-739
13 p.
article
140 Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells Carrascal, Mylène A.
2014
3 p. 753-765
13 p.
article
141 Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer Ma, Xiaoli
2014
3 p. 555-564
10 p.
article
142 Structural and genic characterization of stable genomic regions in breast cancer: Relevance to chemotherapy Park, Nicole I.
2012
3 p. 347-359
13 p.
article
143 Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models Yi, Bo-Rim
2013
3 p. 543-554
12 p.
article
144 Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling Kazi, Julhash U.
2013
3 p. 693-703
11 p.
article
145 Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: An evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice Thakur, Mayank
2013
3 p. 475-483
9 p.
article
146 Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen McCluskey, Andrew J.
2013
3 p. 440-451
12 p.
article
147 The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia Hantschel, Oliver
2008
3 p. 272-281
10 p.
article
148 The cost of hope: Doctors weigh the benefits of new drugs against sky-high costs Loewenberg, Samuel
2010
3 p. 301-303
3 p.
article
149 The epigenetics of breast cancer Jovanovic, Jovana
2010
3 p. 242-254
13 p.
article
150 The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells Sahlberg, Kristine Kleivi
2013
3 p. 392-401
10 p.
article
151 The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression Mussnich, Paula
2013
3 p. 531-542
12 p.
article
152 The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma Montes de Oca, Rocío
2015
3 p. 657-674
18 p.
article
153 The interaction of PKN3 with RhoC promotes malignant growth Unsal-Kacmaz, Keziban
2012
3 p. 284-298
15 p.
article
154 The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer Kashyap, Vasundhra
2013
3 p. 555-566
12 p.
article
155 The MINDACT trial: The first prospective clinical validation of a genomic tool Cardoso, Fatima
2007
3 p. 246-251
6 p.
article
156 The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL Wang, Peng
2013
3 p. 334-345
12 p.
article
157 The state of academic cancer surgery in the UK Eckhouse, S.
2008
3 p. 206-212
7 p.
article
158 The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins Weng, Alexander
2012
3 p. 323-332
10 p.
article
159 The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V Noël, Laura A.
2014
3 p. 728-740
13 p.
article
160 TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles Offenberg, Hanne
2008
3 p. 233-240
8 p.
article
161 TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers Győrffy, Balázs
2014
3 p. 508-519
12 p.
article
162 Tracing the tumor lineage Navin, Nicholas E.
2010
3 p. 267-283
17 p.
article
163 Triple-negative breast cancer: Present challenges and new perspectives Podo, Franca
2010
3 p. 209-229
21 p.
article
164 UK’s adopts systematic approach to personalised cancer medicine Fricker, Janet
2011
3 p. 217-219
3 p.
article
165 Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer Abdel-Fatah, Tarek M.A.
2015
3 p. 569-585
17 p.
article
166 Use of high density antibody arrays to validate and discover cancer serum biomarkers Loch, Christian M.
2007
3 p. 313-320
8 p.
article
167 Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system Stricker, Thomas P.
2014
3 p. 669-678
10 p.
article
168 Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages Lin, Elaine Y.
2007
3 p. 288-302
15 p.
article
169 VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer Gambaro, Karen
2013
3 p. 513-530
18 p.
article
170 Volume contents 2007
3 p. 359-362
4 p.
article
171 Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells Notas, George
2013
3 p. 595-610
16 p.
article
172 Will the Innovative Medicines Initiative really deliver innovative medicines? Wilkinson, Emma
2008
3 p. 203-205
3 p.
article
                             172 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands